[305 Pages Report] The global varicella vaccines market garnered US$ 2.93 Billion in 2021, and is likely to exhibit a Y-o-Y increase of 6.1 % to be valued at US$ 3.11 Billion in 2022. The market is likely to further rise to US$ 5.76 Billion by 2032, at a projected 6.3% CAGR during the 2022-2032 forecast period.
“Rising government initiatives to curb the spread of infectious diseases, ranging from chickenpox to measles, is widening scope for varicella vaccines development, paving way for enhanced market growth prospects.”
Attributes
Details
Anticipated Base Year Value (2021)
US$ 2.93 Billion
Expected Market Value (2022)
US$ 3.11 Billion
Global Varicella Vaccines Market CAGR (2022-2032)
6.3%
Global Varicella Vaccines Market (2032)
US$ 5.76 Billion
Market Share of USA (2021)
24.2%
Global Varicella Vaccines Market Attraction
Government initiatives to curb spread of infectious diseases has led to initiation of extensive awareness and immunization campaigns, driving market growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the factors propelling the global Varicella Vaccines Market?
Growing awareness regarding Vaccination and increasing acceptance of varicella vaccines
Varicella vaccines are mainly used for chickenpox, herpes zoster and mumps, measles, rubella, and varicella immunization. Chickenpox can be serious, especially in babies, adolescents, adults, pregnant women, and people with low immunity systems. Thus immunization in newborns is recommended by the World Health Organization (WHO).
Monovalent varicella vaccine and combination varicella vaccine are available to provide immunity against varicella. Increasing awareness related to the use of varicella vaccines, increasing immunization programs, and the rise in adoption of varicella vaccination worldwide also fuel the growth of the varicella vaccines market. The major factor driving the growth of the varicella vaccines market is government initiatives to increase R&D programs and immunization strategies.
What are the Factors Hampering the Global Varicella Vaccines Market?
The increasing development costs and a lower market value may impede the growth of the market in the coming years. Also, the development of vaccines is a lengthy, complicated, and expensive process as a result vaccine prices are high which may hinder the growth of the market in the forecasting period.
Moreover, lack of awareness and poor healthcare infrastructure across developing regions is another factor affecting the industry’s expansion in the coming years.
Find your sweet spots for generating winning opportunities in this market.
What are the Prevailing Opportunities in the Global Varicella Vaccines Market?
The factor that boosts the growth of the varicella vaccine is a surge in the adoption of varicella vaccination worldwide. Varicella vaccines are more efficient to build immunity against the varicella-zoster virus as the infection can cause serious diseases such as chickenpox and herpes zoster. Immunization against these diseases is necessary as chickenpox can lead to serious complications such as bacterial infections of the skin and soft tissues in children and is also seen in adults in tropical countries like India. Increasing demand for vaccination in many countries is expected to drive the demand for the varicella vaccine market in the coming years.
As per the analysis, the chickenpox segment is anticipated to hold remunerative opportunities for the global varicella vaccines market. Various developing countries are making significant developments in their budgets, thereby, offering lucrative opportunities to players in the market. Also, various governments are initiatives in immunization programs, which is expected to increase the demand for the Varicella vaccines market.
What is the Contribution of Various Segments in Boosting the Market?
Chickenpox Immunization and Herpes Zoster Immunization to Prevail by Application
Based on application, the chickenpox immunization segment is expected to dominate the market. The segment is projected to exhibit a CAGR of 7.1% during the forecast period. Growing companies’ investment in R&D activities for gaining regulatory approvals that ensure the safety and efficacy of the vaccines coupled with increasing initiatives by manufacturers to develop new vaccines are driving the growth of this segment.
On the other hand, the herpes zoster segment is expected to experience rapid growth during the forecast period due to an increase in the geriatric population worldwide and a rising awareness regarding the use of varicella vaccines for herpes zoster. The segment is poised to document a CAGR of 6.4% across the period of assessment.
By type, Monovalent Varicella Vaccines to be deployed the Most
As per the analysis by product, the monovalent segment is expected to lead the market during the forecast period. A market valuation of US$ 2.1 Billion was anticipated, and is likely to document a value CAGR of 6.8% until 2032.
The monovalent segment is expected to grow in the forecasting period as thesevaccines exhibit lesser chances of inducing febrile seizures in children compared to combination vaccines. Also, the ease of availability and presence of a large number of products are the other factors to increasing the growth of the varicella vaccines market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What is the Regional Analysis of the Global Varicella Vaccines Market?
North America to emerge as a Key Player in the Global Market
North America is anticipated to lead the global varicella vaccines market during the forecast period. The market is likely to garner US$ 1.07 Billion while exhibiting a CAGR of 6.7% from 2022 to 2032.
The rapid development of the region can be attributed to the easy availability of varicella live vaccines and the presence of skilled healthcare experts in the region. Amongst all countries, the U.S is expected to be the most opportunistic investment landscape, with an expected market share of 24.2%.
Also, the presence of well-established healthcare infrastructure and increasing healthcare spending are boosting the growth of the overall varicella vaccines market in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S before vaccination chickenpox caused 100 deaths per year since vaccination began the rate reduced by 90% meaning fever than 20 people die from chickenpox every year.
How will Growth Opportunities unfold across the Asia Pacific?
Asia Pacific is anticipated to be one of the fastest-growing region during the forecast period. Within APAC, South Asia is expected to be the most lucrative, accounting for 10.8% market revenue, and a CAGR of 6.1% to be valued at US$ 320 Million.
East Asia is likely to be the second most lucrative, reaching US$ 270 Million. Within East Asia, China is likely to make the most significant contribution, capturing a 5.9% revenue share during the forecast period. The growth of the market can be attributed to the presence of evolving countries such as; India, China, Japan, and others. The government spending on immunization programs and changing attitudes of people towards vaccinations boost the growth of the market.
Also, the penetration of global players in the region and increasing strategic partnerships and investments by players operating in the region are expected to fuel demand for the varicella vaccines market. Increasing investments in research and development activities along with a growing number of clinical trials will provide a strong thrust to the growth of the varicella vaccines market in China positively impact the market growth.
Region-wise Market Shares for the Varicella Vaccines Market
Countries
Estimated Market Share
North America
36.7%
Latin America
7.4%
Europe
26.4%
South Asia
10.8%
East Asia
9.3%
Oceania
4.5%
Middle East & Africa
4.9%
Who are the Key Players of the Global Varicella Vaccines Market?
Eminent players in the global varicella vaccines market include Bio-Med Pvt. Limited, Pfizer Inc., Emcure Pharmaceuticals Limited, Merck & Co Inc., Sanofi, and Novo Medi Sciences among others.
Recent key developments among players include:
In January 2022 - Pfizer Inc. and BioNTech SE announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV) a debilitating, disfiguring, and painful disease that impacts about one in three people in the United States during their lifetime. This is the third collaboration between Pfizer and BioNTech in the infectious diseases field.
In July 2021- GC LabCell and GC Cell announced a merger agreement to combine in an all-stock transaction. The transaction brings together two iconic South Korean biopharmaceutical companies, highly complementary portfolios with a robust broad cell therapy R&D pipeline and cutting-edge manufacturing capabilities to accelerate growth and enhance value creation.
In December 2020 - Sanofi signed a partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases (NTDs) and supporting the WHO in its commitment to sustainably eliminate sleeping sickness before 2030. Sanofi will provide consistent financial support and dedicated disease management, including screening of populations, disease awareness campaigns, capacity building, as well as drug donation.
Key Segments Covered in the Varicella Vaccines Industry Survey
Varicella Vaccine Market by Product:
Monovalent Varicella Vaccines
Combination Varicella Vaccines
Varicella Vaccine Market by Application:
Varicella Vaccines for Chickenpox Immunization
Varicella Vaccines for Herpes Zoster Immunization
Varicella Vaccines for Mumps, measles, rubella & varicella (MMRV) Immunization
Varicella Vaccine Market by End User:
Varicella Vaccines for Hospitals
Varicella Vaccines for Clinics
Varicella Vaccines for Other End Users
Varicella Vaccine Market by Region:
North America Varicella Vaccines Market
Europe Varicella Vaccines Market
South Asia Varicella Vaccines Market
East Asia Varicella Vaccines Market
Oceania Varicella Vaccines Market
Middle East & Africa Varicella Vaccines Market
Latin America Varicella Vaccines Market
Frequently Asked Questions
What is the estimated market value of the global varicella vaccines market in 2021?
The global varicella vaccines market was valued at US$ 2.93 Billion in 2021.
What is the projected CAGR of the global varicella vaccines market until 2032?
The global varicella vaccines market is estimated to grow at a CAGR of 6.3% from 2022 to 2032.
What is the expected market value of the global varicella vaccines market by 2032?
The global varicella vaccines market is predicted to procure US$ 5.76 Billion from 2022 to 2032.
By Application, which category of varicella vaccines is expected to be dominant?
The chickenpox immunization segment is projected to expand at a 7.1% CAGR during the forecast period.
By product, which segment propel the global varicella vaccines market?
Monovalent varicella vaccines are likely to exhibit a 6.8% CAGR from 2022-2032, propelling global market growth.
What is the estimated market value of the U.S market?
The U.S market is expected to account for over 24% market revenue across the coming decade.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) Analysis By Product, 2017-2021
5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product, 2022-2032
5.3.1. Monovalent Vaccine
5.3.2. Combination Vaccine
5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2022-2032
6.3.1. Chickenpox Immunization
6.3.2. Herpes Zoster Immunization
6.3.3. Mumps, Measles, Rubella, and VaricellaBImmunization
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Value (US$ Bn)ed States
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Rest of South Asia
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. Value (US$ Bn)ed States
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Rest of Latin America
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End User
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End User
16.7. U.K.
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End User
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Spain
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Italy
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Rest of Europe
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End User
16.12. China
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Japan
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End User
16.14. South Korea
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End User
16.15. India
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End User
16.16. ASEAN
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End User
16.17. Rest of South Asia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End User
16.18. Australia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End User
16.19. New Zealand
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End User
16.20. GCC Countries
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End User
16.21. South Africa
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End User
16.22. Israel
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2021
16.22.2.1. By Product
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Rest of MEA
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2021
16.23.2.1. By Product
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. GlaxoSmithKline PLC
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Merck & Co. Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. GC Pharma (Green Cross Holdings)
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Bio-Med Pvt Ltd
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Novo Medi Sciences Pvt Ltd
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Takeda Pharmaceutical Company Limited
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Mitsubishi Tanabe Pharma Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Sinovac Biotech Ltd.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Changchun Keygen Biological Products Co.,Ltd (CNBG Subsidiary)
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Sinergium Biotech
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. SK Bioscience Co., Ltd.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Bn) Forecast by Region, 2017-2032
Table 2: Global Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 3: Global Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 4: Global Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 5: North America Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 6: North America Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 7: North America Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 8: North America Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 9: Latin America Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 10: Latin America Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 11: Latin America Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 12: Latin America Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 13: Europe Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 14: Europe Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 15: Europe Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 16: Europe Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 17: East Asia Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 18: East Asia Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 19: East Asia Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 20: East Asia Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 21: South Asia Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 22: South Asia Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 23: South Asia Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 24: South Asia Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 25: Oceania Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 26: Oceania Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 27: Oceania Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 28: Oceania Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 29: MEA Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 30: MEA Market Value (US$ Bn) Forecast by Product, 2017-2032
Table 31: MEA Market Value (US$ Bn) Forecast by Application, 2017-2032
Table 32: MEA Market Value (US$ Bn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Bn) by Product, 2022-2032
Figure 2: Global Market Value (US$ Bn) by Application, 2022-2032
Figure 3: Global Market Value (US$ Bn) by End User, 2022-2032
Figure 4: Global Market Value (US$ Bn) by Region, 2022-2032
Figure 5: Global Market Value (US$ Bn) Analysis by Region, 2017-2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 11: Global Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 14: Global Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 17: Global Market Attractiveness by Product, 2022-2032
Figure 18: Global Market Attractiveness by Application, 2022-2032
Figure 19: Global Market Attractiveness by End User, 2022-2032
Figure 20: Global Market Attractiveness by Region, 2022-2032
Figure 21: North America Market Value (US$ Bn) by Product, 2022-2032
Figure 22: North America Market Value (US$ Bn) by Application, 2022-2032
Figure 23: North America Market Value (US$ Bn) by End User, 2022-2032
Figure 24: North America Market Value (US$ Bn) by Country, 2022-2032
Figure 25: North America Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 31: North America Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 34: North America Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 37: North America Market Attractiveness by Product, 2022-2032
Figure 38: North America Market Attractiveness by Application, 2022-2032
Figure 39: North America Market Attractiveness by End User, 2022-2032
Figure 40: North America Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Market Value (US$ Bn) by Product, 2022-2032
Figure 42: Latin America Market Value (US$ Bn) by Application, 2022-2032
Figure 43: Latin America Market Value (US$ Bn) by End User, 2022-2032
Figure 44: Latin America Market Value (US$ Bn) by Country, 2022-2032
Figure 45: Latin America Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 51: Latin America Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 54: Latin America Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 57: Latin America Market Attractiveness by Product, 2022-2032
Figure 58: Latin America Market Attractiveness by Application, 2022-2032
Figure 59: Latin America Market Attractiveness by End User, 2022-2032
Figure 60: Latin America Market Attractiveness by Country, 2022-2032
Figure 61: Europe Market Value (US$ Bn) by Product, 2022-2032
Figure 62: Europe Market Value (US$ Bn) by Application, 2022-2032
Figure 63: Europe Market Value (US$ Bn) by End User, 2022-2032
Figure 64: Europe Market Value (US$ Bn) by Country, 2022-2032
Figure 65: Europe Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 71: Europe Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 74: Europe Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 77: Europe Market Attractiveness by Product, 2022-2032
Figure 78: Europe Market Attractiveness by Application, 2022-2032
Figure 79: Europe Market Attractiveness by End User, 2022-2032
Figure 80: Europe Market Attractiveness by Country, 2022-2032
Figure 81: East Asia Market Value (US$ Bn) by Product, 2022-2032
Figure 82: East Asia Market Value (US$ Bn) by Application, 2022-2032
Figure 83: East Asia Market Value (US$ Bn) by End User, 2022-2032
Figure 84: East Asia Market Value (US$ Bn) by Country, 2022-2032
Figure 85: East Asia Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 86: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: East Asia Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 89: East Asia Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 90: East Asia Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 91: East Asia Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 92: East Asia Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 93: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 94: East Asia Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 95: East Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 97: East Asia Market Attractiveness by Product, 2022-2032
Figure 98: East Asia Market Attractiveness by Application, 2022-2032
Figure 99: East Asia Market Attractiveness by End User, 2022-2032
Figure 100: East Asia Market Attractiveness by Country, 2022-2032
Figure 101: South Asia Market Value (US$ Bn) by Product, 2022-2032
Figure 102: South Asia Market Value (US$ Bn) by Application, 2022-2032
Figure 103: South Asia Market Value (US$ Bn) by End User, 2022-2032
Figure 104: South Asia Market Value (US$ Bn) by Country, 2022-2032
Figure 105: South Asia Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 106: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: South Asia Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 109: South Asia Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 110: South Asia Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 111: South Asia Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 112: South Asia Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 113: South Asia Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 114: South Asia Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 115: South Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 116: South Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 117: South Asia Market Attractiveness by Product, 2022-2032
Figure 118: South Asia Market Attractiveness by Application, 2022-2032
Figure 119: South Asia Market Attractiveness by End User, 2022-2032
Figure 120: South Asia Market Attractiveness by Country, 2022-2032
Figure 121: Oceania Market Value (US$ Bn) by Product, 2022-2032
Figure 122: Oceania Market Value (US$ Bn) by Application, 2022-2032
Figure 123: Oceania Market Value (US$ Bn) by End User, 2022-2032
Figure 124: Oceania Market Value (US$ Bn) by Country, 2022-2032
Figure 125: Oceania Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: Oceania Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 131: Oceania Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 134: Oceania Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 137: Oceania Market Attractiveness by Product, 2022-2032
Figure 138: Oceania Market Attractiveness by Application, 2022-2032
Figure 139: Oceania Market Attractiveness by End User, 2022-2032
Figure 140: Oceania Market Attractiveness by Country, 2022-2032
Figure 141: MEA Market Value (US$ Bn) by Product, 2022-2032
Figure 142: MEA Market Value (US$ Bn) by Application, 2022-2032
Figure 143: MEA Market Value (US$ Bn) by End User, 2022-2032
Figure 144: MEA Market Value (US$ Bn) by Country, 2022-2032
Figure 145: MEA Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 148: MEA Market Value (US$ Bn) Analysis by Product, 2017-2032
Figure 149: MEA Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 151: MEA Market Value (US$ Bn) Analysis by Application, 2017-2032
Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 154: MEA Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 157: MEA Market Attractiveness by Product, 2022-2032
Figure 158: MEA Market Attractiveness by Application, 2022-2032
Figure 159: MEA Market Attractiveness by End User, 2022-2032
Figure 160: MEA Market Attractiveness by Country, 2022-2032
